Envestnet Asset Management Inc Akari Therapeutics PLC Transaction History

Envestnet Asset Management Inc

  • $302 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 09, 2020
SELL
$1.58 - $2.37 $20,873 - $31,310
-13,211 Closed
0 $0
Q2 2020

Jul 08, 2020
BUY
$1.16 - $2.61 $1,691 - $3,805
1,458 Added 12.41%
13,211 $29,000
Q1 2020

Apr 23, 2020
BUY
$1.06 - $2.16 $1,382 - $2,816
1,304 Added 12.48%
11,753 $17,000
Q4 2019

Feb 11, 2020
BUY
$1.69 - $2.16 $17,658 - $22,569
10,449 New
10,449 $18,000

About Akari Therapeutics Plc

AKTX Quotes by TradingView
  • Ticker AKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,349,200
  • Market Cap $59.3M
  • Description
  • Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-...
More about AKTX
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email